View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Brentuximab Vedotin 1.8 / Cyclophosphamide 1250 / Doxorubicin 40 / Etoposide 150 / Dacarbazine 250 / Dexamethasone 40, Hodgkin Lymphoma
Protocol-ID: 962 V2.0 (Mini), BrECADD (BRNT1.8/CYCL1250/DOXO40/ETOP150/DCRB250/DEXA40), HodgkinIndication(s)
- Hodgkin Lymphoma; ICD-10 C81.-
Links
- Borchmann BreCADD, ASCO 2024 [DOI]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 16.01.2024